Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 20, 2026, titled "Emcure to Expand the Use of Poviztra® for MASH Indication Following CDSCO Approval".
Emcure Pharmaceuticals Limited Press Release Jul 20 2026
Earlier from Emcure Pharmaceuticals
- Emcure Pharmaceuticals Limited Press Release Jul 13 2026
- Press Release Apr 02 2026
- Press Release Mar 02 2026
- Press Release Dec 22 2025